Sharon Mates Intra Cellular Therapies, Inc. (ITCI) insider trading activity

ITCI Quotes by TradingView

Sharon Mates is Chairman and CEO of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 1.14 Million shares of ITCI, which is worth approximately $149 Million. The most recent transaction as insider was on Mar 10, 2025, when has been sold 10,129 shares (Common Stock) at a price of $131.24 per share, resulting in proceeds of $1,329,329. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M
6.06% 3M change
8.09% 12M change
Total Value Held $149 Million

Sharon Mates Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2025
SELL
Payment of exercise price or tax liability
$1,329,329 $131.24 p/Share
10,129 Reduced 0.88%
1,135,235 Common Stock
Mar 10 2025
BUY
Exercise of conversion of derivative security
-
20,566 Added 1.76%
1,145,364 Common Stock
Mar 06 2025
SELL
Payment of exercise price or tax liability
$2,603,859 $131.19 p/Share
19,848 Reduced 1.73%
1,124,798 Common Stock
Mar 06 2025
BUY
Exercise of conversion of derivative security
-
40,712 Added 3.43%
1,144,646 Common Stock
Mar 01 2025
SELL
Payment of exercise price or tax liability
$2,176,579 $128.2 p/Share
16,978 Reduced 1.51%
1,103,934 Common Stock
Mar 01 2025
BUY
Exercise of conversion of derivative security
-
34,969 Added 3.03%
1,120,912 Common Stock
Jan 31 2025
SELL
Payment of exercise price or tax liability
$1,934,591 $127.0 p/Share
15,233 Reduced 1.38%
1,085,943 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
30,847 Added 2.72%
1,101,176 Common Stock
Dec 05 2024
SELL
Open market or private sale
$4,362,192 $84.38 p/Share
51,697 Reduced 4.61%
1,070,329 Common Stock
Dec 05 2024
BUY
Exercise of conversion of derivative security
$658,102 $12.73 p/Share
51,697 Added 4.4%
1,122,026 Common Stock
Dec 04 2024
SELL
Open market or private sale
$4,376,310 $85.81 p/Share
51,000 Reduced 4.55%
1,070,329 Common Stock
Dec 04 2024
BUY
Exercise of conversion of derivative security
$649,230 $12.73 p/Share
51,000 Added 4.35%
1,121,329 Common Stock
Aug 30 2024
SELL
Open market or private sale
$2,511,939 $73.03 p/Share
34,396 Reduced 3.11%
1,070,329 Common Stock
Aug 30 2024
BUY
Exercise of conversion of derivative security
$437,861 $12.73 p/Share
34,396 Added 3.02%
1,104,725 Common Stock
Aug 29 2024
SELL
Open market or private sale
$2,593,751 $72.85 p/Share
35,604 Reduced 3.22%
1,070,329 Common Stock
Aug 29 2024
BUY
Exercise of conversion of derivative security
$453,238 $12.73 p/Share
35,604 Added 3.12%
1,105,933 Common Stock
Aug 28 2024
SELL
Open market or private sale
$2,394,220 $73.22 p/Share
32,699 Reduced 2.96%
1,070,329 Common Stock
Aug 28 2024
BUY
Exercise of conversion of derivative security
$574,521 $17.57 p/Share
32,699 Added 2.88%
1,103,028 Common Stock
Aug 27 2024
SELL
Open market or private sale
$2,982,972 $73.63 p/Share
40,513 Reduced 3.65%
1,070,329 Common Stock
Aug 27 2024
BUY
Exercise of conversion of derivative security
$711,813 $17.57 p/Share
40,513 Added 3.52%
1,110,842 Common Stock
Aug 26 2024
SELL
Open market or private sale
$1,694,162 $74.59 p/Share
22,713 Reduced 2.08%
1,070,329 Common Stock
Aug 26 2024
BUY
Exercise of conversion of derivative security
$399,067 $17.57 p/Share
22,713 Added 2.04%
1,093,042 Common Stock
Aug 23 2024
SELL
Open market or private sale
$2,135,512 $74.46 p/Share
28,680 Reduced 2.61%
1,070,329 Common Stock
Aug 23 2024
BUY
Exercise of conversion of derivative security
$503,907 $17.57 p/Share
28,680 Added 2.54%
1,099,009 Common Stock
Aug 22 2024
SELL
Open market or private sale
$2,954,681 $75.03 p/Share
39,380 Reduced 3.55%
1,070,329 Common Stock
SM

Sharon Mates

Chairman and CEO
New York, NY

Track Institutional and Insider Activities on ITCI

Follow Intra-Cellular Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

News

Receive news related to Intra-Cellular Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITCI